science
-
Isomorphic Labs and the AI Revolution in Drug Discovery: Toward a Computable Biology
In a development emblematic of the growing entanglement between advanced artificial intelligence research and the life sciences, Isomorphic Labs—a London-based enterprise conceived in 2021 as a spin-off of Alphabet’s renowned AI research unit, DeepMind—has secured $600 million in external financing in its inaugural funding round. The round was led by Thrive Capital, with substantial participation…